Teladoc Health, Inc. is a multinational telemedicine and virtual healthcare company founded in 2002. Headquartered in New York City, its services include telehealth, employer-sponsored health plans, 24/7 care, mental health, diabetes and hypertension management, primary care, prescriptions, medical opinions, AI and analytics, telehealth devices and licensable platform services.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| TDOC | Teladoc Health, Inc. | 2026-04-02 18:22:16 | 5.28 | 0.01 | 0.19 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TDOC | 0001477449 | Teladoc Health, Inc. | US87918A1051 | 549300I2PVFBC9MFAC61 | 043705970 | NYSE | 8011 | Services-Offices & Clinics of Doctors of Medicine | 1231 | DE | 155 E 44TH STREET | NEW YORK | NY | 10017 | UNITED STATES | US | 2036352002 | 155 E 44TH STREET, NEW YORK, NY, 10017 | 155 E 44TH STREET, NEW YORK, NY, 10017 | Teladoc, Inc. | Medical care | 2002 | Chuck Divita, III | 5,000 | http://teladochealth.com | 1,531,762,802 | 178,315,400 | 178,396,434 | Teladoc Health, Inc. is a multinational telemedicine and virtual healthcare company founded in 2002. Headquartered in New York City, its services include telehealth, employer-sponsored health plans, 24/7 care, mental health, diabetes and hypertension management, primary care, prescriptions, medical opinions, AI and analytics, telehealth devices and licensable platform services. | 2026-04-02 17:26:12 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 1,531,762,802 | -134,308,902 | -8.0614 | 178,396,434 | 4,724,402 | 2.7203 |
| 2024 | 1,666,071,704 | -2,478,568,464 | -59.8018 | 173,672,032 | 6,633,066 | 3.971 |
| 2023 | 4,144,640,168 | -1,189,394,842 | -22.2982 | 167,038,966 | 4,421,774 | 2.7191 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Adam C. Vandervoort | Chief Legal Officer, Secretary | 2024 | 466,667 | 94,000 | 1,929,852 | 130,000 | 13,800 | 2,634,319 |
| Kelly Bliss | President | 2024 | 467,841 | 90,600 | 1,752,498 | 190,000 | 13,800 | 2,514,739 |
| Charles Divita | Chief Executive Officer | 2024 | 450,000 | 0 | 15,028,180 | 448,087 | 135,000 | 16,061,267 |
| Mala Murthy | Chief Financial Officer | 2024 | 566,252 | 0 | 4,430,642 | 220,000 | 13,800 | 5,230,694 |
| Carlos Nueno | President | 2024 | 502,214 | 97,527 | 1,643,530 | 410,878 | 84,989 | 2,739,138 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 5,600 |
| 2024 | 5,500 |
| 2023 | 5,600 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 2,529,977,000 | 2,569,574,000 | 2,602,415,000 |
| Cost Of Revenue | 771,593,000 | 751,270,000 | 760,031,000 |
| Gross Profit | — | — | — |
| Research And Development Expenses | 277,922,000 | 307,274,000 | 348,521,000 |
| General And Administrative Expenses | 431,891,000 | 435,490,000 | 464,659,000 |
| Operating Expenses | 2,792,932,000 | 3,590,460,000 | 2,850,968,000 |
| Operating Income | -262,955,000 | -1,020,886,000 | -248,553,000 |
| Net Income | -200,322,000 | -1,001,245,000 | -220,368,000 |
| Earnings Per Share Basic | -1.14 | -5.87 | -1.34 |
| Earnings Per Share Diluted | -1.14 | -5.87 | -1.34 |
| Weighted Average Shares Outstanding Basic | 176,221,530 | 170,564,088 | 164,578,219 |
| Weighted Average Shares Outstanding Diluted | 176,221,530 | 170,564,088 | 164,578,219 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 781,084,000 | 1,298,327,000 | 1,123,675,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 192,826,000 | 214,146,000 | 217,423,000 |
| Inventories | 38,203,000 | 38,138,000 | 29,513,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 2,071,000 | 2,828,000 | 7,443,000 |
| Total Assets Current | 1,119,129,000 | 1,663,907,000 | 1,489,048,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 26,972,000 | 29,487,000 | 32,032,000 |
| Other Assets Non Current | 105,803,000 | 81,488,000 | 80,258,000 |
| Total Assets Non Current | 26,972,000 | 29,487,000 | 32,032,000 |
| Total Assets | 2,858,300,000 | 3,516,524,000 | 4,392,369,000 |
| Accounts Payable | 47,967,000 | 33,130,000 | 43,637,000 |
| Deferred Revenue | 62,305,000 | 79,296,000 | 95,659,000 |
| Short Term Debt | — | — | — |
| Other Liabilities Current | 22,942,000 | 27,427,000 | 33,691,000 |
| Total Liabilities Current | 404,738,000 | 941,535,000 | 420,616,000 |
| Long Term Debt | 994,925,000 | 991,418,000 | 1,538,688,000 |
| Other Liabilities Non Current | 643,000 | 720,000 | 1,080,000 |
| Total Liabilities Non Current | 1,067,856,000 | 1,083,910,000 | — |
| Total Liabilities | 1,472,594,000 | 2,025,445,000 | — |
| Common Stock | 178,000 | 173,000 | 167,000 |
| Retained Earnings | -16,430,222,000 | -16,229,900,000 | -15,228,655,000 |
| Accumulated Other Comprehensive Income | -34,728,000 | -38,388,000 | -36,990,000 |
| Total Shareholders Equity | 1,385,706,000 | 1,491,079,000 | 2,326,073,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | — | — | — |
| Share Based Compensation Expense | 80,414,000 | 145,951,000 | 201,550,000 |
| Other Non Cash Income Expense | -6,399,000 | -9,796,000 | 310,000 |
| Change In Accounts Receivable | -25,126,000 | 375,000 | 10,252,000 |
| Change In Inventories | -399,000 | 9,749,000 | -24,095,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | -7,997,000 | 1,257,000 | 23,052,000 |
| Change In Accounts Payable | 11,454,000 | -10,365,000 | -4,185,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 294,357,000 | 293,680,000 | 350,021,000 |
| Purchases Of Marketable Securities | 27,875,000 | — | — |
| Sales Of Marketable Securities | — | 0 | 0 |
| Acquisition Of Property Plant And Equipment | 8,893,000 | 10,790,000 | 11,464,000 |
| Acquisition Of Business | 81,904,000 | — | 0 |
| Other Investing Activities | -60,000 | 0 | -1,000 |
| Cash From Investing Activities | -266,003,000 | -124,052,000 | -156,347,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | 3,000,000 | — | — |
| Repurchase Of Common Stock | — | — | — |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | — | — | — |
| Other Financing Activities | 0 | -2,000 | 0 |
| Cash From Financing Activities | -551,652,000 | 8,312,000 | 10,854,000 |
| Change In Cash | -523,298,000 | 177,940,000 | 204,528,000 |
| Cash At End Of Period | 781,084,000 | 1,298,327,000 | 1,123,675,000 |
| Income Taxes Paid | 8,745,000 | 8,946,000 | 7,238,000 |
| Interest Paid | 15,008,000 | 17,322,000 | 17,422,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | -1.14 | -5.87 | -1.34 |
| Price To Earnings Ratio | -6.1404 | -1.5486 | -16.0821 |
| Earnings Growth Rate | -80.5792 | 338.0597 | -98.4161 |
| Price Earnings To Growth Ratio | 0.0762 | -0.0046 | 0.1634 |
| Book Value Per Share | 7.8634 | 8.742 | 24.1329 |
| Price To Book Ratio | 0.8902 | 1.0398 | 0.893 |
| Ebitda | — | — | — |
| Enterprise Value | 1,447,391,710 | 1,243,518,559.92 | 3,961,673,619.45 |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | 0.718 | 0.6649 | 0.6615 |
| Capital Expenditures | — | — | — |
| Free Cash Flow | — | — | — |
| Return On Equity | -0.1446 | -0.6715 | -0.0947 |
| One Year Beta | 1.391 | 1.4728 | 2.2992 |
| Three Year Beta | 1.6209 | 1.9436 | 1.9197 |
| Five Year Beta | 1.7307 | 1.0134 | 1.0506 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Catapano Joseph Ronald | Chief Accounting Officer | 2026-04-02 | 675 | D | 10,249 |
| Catapano Joseph Ronald | Chief Accounting Officer | 2026-04-01 | 2,083 | A | 10,924 |
| Catapano Joseph Ronald | Chief Accounting Officer | 2026-04-01 | 2,083 | D | 12,501 |
| SALKA SUSAN R | Director | 2026-03-30 | 48,638 | A | 48,638 |
| DIVITA CHARLES III | Director, CHIEF EXECUTIVE OFFICER | 2026-03-11 | 27,731 | D | 364,784 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Donald Sternoff Beyer | 2020-05-12 | VA08 | Sale | 2020-04-27 | Joint | $1,001 - $15,000 |
| Bradley S. Schneider | 2018-07-15 | IL10 | Purchase | 2017-06-04 | Spouse | $15,001 - $50,000 |
| Bradley S. Schneider | 2018-06-10 | IL10 | Purchase | 2018-05-04 | Spouse | $100,001 - $250,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| ADIRONDACK TRUST CO | 2026-03-31 | 1,782 | 327 | 5.4495 |
| GOLDMAN SACHS GROUP INC | 2025-12-31 | 13,471,731 | 1,924,533 | 7 |
| HSBC HOLDINGS PLC | 2025-12-31 | 159,621 | 23,000 | 6.94 |
| Qube Research & Technologies Ltd | 2025-12-31 | 79,800 | 11,400 | 7 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 2025-12-31 | 1,205,190 | 172,170 | 7 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| Global X Funds | 2026-01-31 | Global X Russell 2000 ETF | RSSL | 80,506 | 438,757.7 | 0.0317 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 2026-01-31 | Invesco NASDAQ Internet ETF | PNQI | 31,509 | 171,724.05 | 0.0255 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 2026-01-31 | Invesco RAFI US 1000 ETF | PRF | 124,932 | 680,879.4 | 0.0077 |
| VANGUARD EXPLORER FUND | 2026-01-31 | Admiral Shares | VEXRX | 775,333 | 4,225,564.85 | 0.0203 |
| VANGUARD EXPLORER FUND | 2026-01-31 | Investor Shares | VEXPX | 775,333 | 4,225,564.85 | 0.0203 |